NFA
LJPC

Nationwide Fund Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Nationwide Fund Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,618
Closed -$335K – 3183
2017
Q3 		$335K Sell
9,618
-334
-3% -$10.7K ﹤0.01% 2385
2017
Q2 		$296K Buy
9,952
+1,688
+20% +$48.4K ﹤0.01% 2450
2017
Q1 		$247K Sell
8,264
-920
-10% -$23.5K ﹤0.01% 2493
2016
Q4 		$161K Hold
9,184
– – ﹤0.01% 2705
2016
Q3 		$218K Hold
9,184
– – ﹤0.01% 2582
2016
Q2 		$147K Buy
9,184
+491
+6% +$8.81K ﹤0.01% 2755
2016
Q1 		$182K Sell
8,693
-32
-0.4% -$571 ﹤0.01% 2577
2015
Q4 		$236K Buy
8,725
+906
+12% +$24.7K ﹤0.01% 2464
2015
Q3 		$217K Buy
7,819
+391
+5% +$12.3K ﹤0.01% 2526
2015
Q2 		$182K Buy
+7,428
New +$153K ﹤0.01% 2757

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's LJPC Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2017, closing a stake of 9,618 shares — an estimated $335K sold.

Nationwide Fund Advisors first reported a position in LJPC in Q2 2015 and held it in 10 quarters. The position peaked at $335K in Q3 2017. 93 funds tracked by Wall St. Rank hold LJPC as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 9,618 La Jolla Pharmaceutical Company shares in Q4 2017, an estimated $335K.
  • Nationwide Fund Advisors first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 10 quarters.
  • Nationwide Fund Advisors's La Jolla Pharmaceutical Company position peaked at $335K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.